• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

林奇综合征与泌尿系统恶性肿瘤:当代综述

Lynch syndrome and urologic malignancies: a contemporary review.

作者信息

Lim Amy, Rao Priya, Matin Surena F

机构信息

Department of Urology.

Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

出版信息

Curr Opin Urol. 2019 Jul;29(4):357-363. doi: 10.1097/MOU.0000000000000639.

DOI:10.1097/MOU.0000000000000639
PMID:31045926
Abstract

PURPOSE OF REVIEW

An overview of urologic malignancies in Lynch syndrome and the current state of research.

RECENT FINDINGS

Upper tract urothelial carcinoma (UTUC) is the third most common malignancy in Lynch syndrome. Establishment and utilization of a sensitive and practical screening method for Lynch syndrome in patients presenting with UTUC is overdue. Next-generation sequencing to evaluate for microsatellite instability (MSI) and detect mutations of mismatch repair (MMR) genes may be the future of Lynch syndrome screening. Epidemiologic data and molecular characterization suggest bladder urothelial carcinoma (BUC) and prostate cancer (PCA) as unrecognized components of Lynch syndrome. Small studies suggest that Lynch syndrome may predispose individuals to adrenocortical carcinoma. Testicular cancer literature focuses on characterizing MSI and MMR gene expression as it relates to chemotherapy sensitivity; outcomes suggest a potential avenue to investigate its relationship to Lynch syndrome.

SUMMARY

Patients with Lynch syndrome have an increased risk of urologic malignancies, including UTUC and likely BUC and PCA. BUC and PCA have a lower penetrance than UTUC for unknown reasons. Established Lynch syndrome-associated genitourinary tumors will necessitate the development of methods to diagnose Lynch syndrome in patients presenting with these malignancies, in addition to establishing screening guidelines for patients with Lynch syndrome-associated genitourinary tumors.

摘要

综述目的

概述林奇综合征中的泌尿系统恶性肿瘤及当前研究现状。

最新发现

上尿路尿路上皮癌(UTUC)是林奇综合征中第三常见的恶性肿瘤。对于患有UTUC的患者,建立并应用一种敏感且实用的林奇综合征筛查方法已刻不容缓。通过新一代测序评估微卫星不稳定性(MSI)并检测错配修复(MMR)基因的突变可能是未来林奇综合征筛查的方向。流行病学数据和分子特征表明,膀胱尿路上皮癌(BUC)和前列腺癌(PCA)是林奇综合征中未被认识的组成部分。小型研究表明,林奇综合征可能使个体易患肾上腺皮质癌。睾丸癌相关文献主要关注MSI和MMR基因表达与化疗敏感性的关系;研究结果提示了一条研究其与林奇综合征关系的潜在途径。

总结

林奇综合征患者患泌尿系统恶性肿瘤的风险增加,包括UTUC,可能还有BUC和PCA。由于不明原因,BUC和PCA的外显率低于UTUC。除了为林奇综合征相关泌尿生殖系统肿瘤患者制定筛查指南外,已确定的林奇综合征相关泌尿生殖系统肿瘤还需要开发针对患有这些恶性肿瘤患者的林奇综合征诊断方法。

相似文献

1
Lynch syndrome and urologic malignancies: a contemporary review.林奇综合征与泌尿系统恶性肿瘤:当代综述
Curr Opin Urol. 2019 Jul;29(4):357-363. doi: 10.1097/MOU.0000000000000639.
2
Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.所有上尿路尿路上皮癌均应进行普遍林奇综合征筛查。
Am J Surg Pathol. 2018 Nov;42(11):1549-1555. doi: 10.1097/PAS.0000000000001141.
3
Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.在一家日本医院人群中,上尿路尿路上皮癌患者中林奇综合征的患病率。
Jpn J Clin Oncol. 2020 Jan 24;50(1):80-88. doi: 10.1093/jjco/hyz140.
4
Lynch syndrome in urological practice: diagnosis, therapeutic strategies, and screening for upper tract urothelial carcinoma.泌尿外科临床中的林奇综合征:诊断、治疗策略及上尿路尿路上皮癌的筛查
Curr Opin Urol. 2022 Jan 1;32(1):40-47. doi: 10.1097/MOU.0000000000000936.
5
Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.在全面筛查中DNA错配修复蛋白免疫组化表达缺失的上尿路尿路上皮癌患者的临床病理特征
Int J Urol. 2018 Feb;25(2):151-156. doi: 10.1111/iju.13481. Epub 2017 Nov 22.
6
Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌患者林奇综合征的通用即时检测
J Urol. 2018 Jan;199(1):60-65. doi: 10.1016/j.juro.2017.08.002. Epub 2017 Aug 7.
7
Molecular subtype classification of urothelial carcinoma in Lynch syndrome.林奇综合征中尿路上皮癌的分子亚型分类。
Mol Oncol. 2018 Aug;12(8):1286-1295. doi: 10.1002/1878-0261.12325. Epub 2018 Jun 19.
8
Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.上尿路尿路上皮细胞癌及其他涉及遗传性非息肉病性结直肠癌(林奇综合征)肿瘤谱的泌尿生殖系统恶性肿瘤。
Eur Urol. 2008 Dec;54(6):1226-36. doi: 10.1016/j.eururo.2008.08.008. Epub 2008 Aug 12.
9
Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.林奇综合征及林奇综合征模拟病症:遗传性结肠癌日益复杂的格局。
World J Gastroenterol. 2015 Aug 21;21(31):9253-61. doi: 10.3748/wjg.v21.i31.9253.
10
[Should we systematically screen for Lynch syndrome in patients with upper urinary tract carcinoma?].[我们是否应该对上尿路癌患者进行林奇综合征的系统筛查?]
Bull Cancer. 2014 Feb;101(2):144-50. doi: 10.1684/bdc.2014.1896.

引用本文的文献

1
Clinical Implications of the Molecular and Genomic Landscape of Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌的分子和基因组特征的临床意义。
Curr Urol Rep. 2024 Oct 8;26(1):11. doi: 10.1007/s11934-024-01245-1.
2
Iatrogenic Causes of Urothelial Cancer of the Upper Urinary Tract and Bladder.上尿路和膀胱尿路上皮癌的医源性病因
Bladder Cancer. 2021 Aug 31;7(3):385-387. doi: 10.3233/BLC-219608. eCollection 2021.
3
Diagnosis of patients with Lynch syndrome lacking the Amsterdam II or Bethesda criteria.对不符合阿姆斯特丹II标准或贝塞斯达标准的林奇综合征患者的诊断。
Hered Cancer Clin Pract. 2023 Oct 20;21(1):21. doi: 10.1186/s13053-023-00266-0.
4
Minimally Invasive Radical Nephroureterectomy: 5-Year Update of Techniques and Outcomes.微创根治性肾输尿管切除术:技术与结果的5年更新
Cancers (Basel). 2023 Sep 15;15(18):4585. doi: 10.3390/cancers15184585.
5
Cyberknife Radiosurgery for Prostate Cancer after Abdominoperineal Resection (CYRANO): The Combined Computer Tomography and Electromagnetic Navigation Guided Transperineal Fiducial Markers Implantation Technique.Cyberknife 立体定向放射外科治疗经腹会阴联合切除术(CYRANO)后的前列腺癌:计算机断层扫描和电磁导航引导经会阴 fiducial 标记植入技术。
Curr Oncol. 2023 Aug 28;30(9):7926-7935. doi: 10.3390/curroncol30090576.
6
Risk of malignancy in adrenal tumors in patients with a history of cancer.有癌症病史患者肾上腺肿瘤的恶性风险
Front Oncol. 2023 Mar 27;13:1018475. doi: 10.3389/fonc.2023.1018475. eCollection 2023.
7
Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling.基于免疫基因组分析鉴定肾上腺皮质癌的免疫特异性亚型。
Biomolecules. 2023 Jan 4;13(1):104. doi: 10.3390/biom13010104.
8
Genitourinary manifestations of Lynch syndrome in the urological practice.林奇综合征在泌尿外科临床中的泌尿生殖系统表现
Asian J Urol. 2022 Oct;9(4):443-450. doi: 10.1016/j.ajur.2022.05.009. Epub 2022 Aug 31.
9
Prognostic value of the endothelial activation and stress index in patients with upper tract urothelial cancer undergoing radical nephroureterectomy.在上尿路尿路上皮癌行根治性肾输尿管切除术的患者中,内皮激活和应激指数的预后价值。
Investig Clin Urol. 2022 Nov;63(6):623-630. doi: 10.4111/icu.20220204.
10
The interplay of cell cycle and DNA repair gene alterations in upper tract urothelial carcinoma: predictive and prognostic implications.上尿路尿路上皮癌中细胞周期与DNA修复基因改变的相互作用:预测和预后意义
Precis Clin Med. 2020 Jun 3;3(3):153-160. doi: 10.1093/pcmedi/pbaa020. eCollection 2020 Sep.